Gene · 1573
CYP2J2: cytochrome P450 family 2 subfamily J member 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CYP2J2: cytochrome P450 family 2 subfamily J member 2. Genes, record 1573. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1573
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P51589 | Cytochrome P450 2J2 | 502 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 42880 | P51589 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 3891 | P51589 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6101 | P51589 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6101 | P51589 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 27022 | P51589 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 3891 | P51589 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 3891 | P51589 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 27022 | P51589 | Espacenet |
| JP 2024112982 A | 2024-08-21 | 4417 | P51589 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 3898 | P51589 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants819
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CYP2J2 papers | Newest fiscal year |
|---|---|---|---|
| ZIAES025034 | Characterization And Functional Significance Of P450 Arachidonate Epoxygenases | 52 | 2025 |
| R35ES030443 | Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases | 9 | 2025 |
| ZIAES025043 | Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice | 6 | 2025 |
| T32ES007059 | Advanced Training in Environmental Health Sciences | 4 | 2025 |
| T32HL086350 | Training Program in Basic and Translational Cardiovascular Science | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30DK026743 | UCSF Liver Center | 3 | 2025 |
| P30ES007033 | University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment | 3 | 2025 |
| R01HL085844 | Functional interactions of cardiac ion channels | 3 | 2025 |
| R35GM118145 | Nanoscale Approaches to Understanding Membrane Protein Function | 3 | 2025 |
1 to 10 of 819Source NIH's project files
See all 819 nih grantsPapers1,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunohistochemical and Transcriptomic Assessment of Cytochrome 2J2 in Prostate and Renal Cancer. | Cancers (Basel) | 2026 | 42738330 | PubTator, text mining | PubMed |
| Exploring and validating hub genes associated with atopic dermatitis through weighted gene co-expression network analysis and machine learning. | Medicine (Baltimore) | 2026 | 42629711 | PubTator, text mining | PubMed |
| Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice. | Pharmaceutics | 2026 | 42514961 | PubTator, text mining | PubMed |
| Alterations in Epoxyeicosatrienoic Acids Metabolism in Type 2 Diabetes Mellitus and Potential Association with Retinopathy Progression. | Curr Med Chem | 2026 | 42487591 | PubTator, text mining | PubMed |
| New Insights into Genetic Polymorphisms Influencing the Therapeutic Efficacy and Toxicity of Rivaroxaban. | J Clin Pharmacol | 2026 | 42394189 | PubTator, text mining | PubMed |
| PTX3 facilitates tumor cell migration and invasion through the miR-1255b-2-3p/CYP2J2 axis in oral squamous cell carcinoma. | Cancer Cell Int | 2026 | 42393690 | PubTator, text mining | PubMed |
| Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitor. | Drug Metab Dispos | 2026 | 42285009 | PubTator, text mining | PubMed |
| Differential effects of lipid composition on the thermal and functional properties of membrane associated CYP2J2. | Protein Sci | 2026 | 42249805 | PubTator, text mining | PubMed |
| Placental CYP450 gene dysregulation by maternal PFAS: a novel mechanism linking prenatal exposure to altered toddler growth. | Environ Health | 2026 | 42231393 | PubTator, text mining | PubMed |
| An integrated computational framework for hazard identification of emerging contaminants: a case study of 6PPD. | Environ Int | 2026 | 42225002 | PubTator, text mining | PubMed |
1 to 10 of 1,413
See all 1,413 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1573
GET https://conductscience.org/api/genes/v1/1573/patents?page=2